Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
19 hedge funds and large institutions have $2.21M invested in Histogen Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 13 closing their positions.
42% more capital invested
Capital invested by funds: $1.56M → $2.21M (+$648K)
30% less funds holding
Funds holding: 27 → 19 (-8)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
62% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$358K |
| 2 |
IIA
IPG Investment Advisors
San Diego,
California
|
+$168K |
| 3 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
+$141K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$12.3K |
| 5 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$420 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JC
JBF Capital
Aspen,
Colorado
|
-$161K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$22.3K |
| 3 |
QP
Quilter Plc
London,
United Kingdom
|
-$19K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$17K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$16K |
HSTO Hedge Fund Activity: Q2 2020 in Review
19 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q2 2020, worth a combined $2.21M — up 42% from $1.56M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of HSTO and 5 opened new positions — a net loss of 8 holders — while 5 trimmed existing stakes and 2 added.
The largest buyer was Renaissance Technologies, adding an estimated $358K. The largest seller was JBF Capital, exiting entirely with an estimated $161K sold.
- 19 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q2 2020, down from 27 in Q1 2020.
- Funds reported $2.21M of Histogen Inc. Common Stock stock for Q2 2020, up 42% quarter-over-quarter.
- 5 funds opened new Histogen Inc. Common Stock positions in Q2 2020 and 13 closed out, a net change of -8 holders.
- The largest Histogen Inc. Common Stock buyer in Q2 2020 was Renaissance Technologies, an estimated $358K added.
- The largest Histogen Inc. Common Stock seller in Q2 2020 was JBF Capital, an estimated $161K sold.
Based on aggregated 13F filings for Q2 2020.